| 0.789 Data as of Jun 17 | +0.039 / +5.20%Today’s Change | 0.62 Today|||52-Week Range 1.86 | -21.10% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Generic | MARKET CAP $8.7M |
Company Description
BioStar Pharmaceuticals, Inc., engages in developing, manufacturing and marketing pharmaceutical and medical nutrient products for a variety of diseases and conditions. Its products are: AoXing Oleanlic Acid Capsule (treatment for Hepatitis B), Danshen Granule (treatment for coronory heart disease,myocarditis and angina pectoris), GanWang (treatment for colds, runny nose, sore throat, headache and fever), Taohuasan (treatment for bronchial congestion and coughs) and Tianqi Dysmenorrhea Capsule (treatment for dysmenorrhea). The company was founded on March 27, 2007 and is headquartered in Xianyang, China
Employees

Shareholders
| Other institutional | 1.73% |
| Individual stakeholders | 0.09% |
| Mutual fund holders | 0.00% |
Top Executives
| Rong Hua Wang | Chairman, President & Chief Executive Officer |
| Zhenghong Wang | Chief Operating Officer |
| Qinghua Liu | Chief Financial Officer & Director |
| Gong Shuang | Corporate Secretary & Director-Administration |
| Jianmin Du | General Manager |